The Impact of the Self-medication Taxation System on Drug Cost Control (Japanese)

Kohei Nishikawa and Hiroshi Ohashi

Discussion Papers (Japanese) from Research Institute of Economy, Trade and Industry (RIETI)

Abstract: Self-medication in the form of self-care of our health is popular in many countries. To help promote self-medication and ultimately aim to contain medical expenditures, Japan introduced a self-medication taxation system in 2017. It is not clear however whether the self-medication taxation system has reduced drug costs, as pointed out by the expert committee of the Japanese government. This paper examines the impact of the self-medication taxation system on drug cost control, using receipt data. Our analysis on the allergic rhinitis drug market indicates that the self-medication tax would reduce both the frequency of patient visits to hospitals and clinics, and the volume of prescriptions per visit. Based on these estimates, simulation is conducted to assess a counterfactual situation where there is no self-medication taxation system. As a result of changes in physician prescribing behavior, drug costs decrease by 4.9%. Furthermore, including the effect of a decrease in the frequency of patient visits, the simulation results indicate that drug expenditure is reduced by 5.8% through the self-medication tax system.

Pages: 31 pages
Date: 2022-10
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.rieti.go.jp/jp/publications/dp/22j039.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eti:rdpsjp:22039

Access Statistics for this paper

More papers in Discussion Papers (Japanese) from Research Institute of Economy, Trade and Industry (RIETI) Contact information at EDIRC.
Bibliographic data for series maintained by TANIMOTO, Toko ().